Jasiecka-Mikołajczyk, A.; Jaroszewski, J.J.; Maślanka, T.
Oclacitinib, a Janus Kinase Inhibitor, Reduces the Frequency of IL-4- and IL-10-, but Not IFN-γ-, Producing Murine CD4+ and CD8+ T Cells and Counteracts the Induction of Type 1 Regulatory T Cells. Molecules 2021, 26, 5655.
https://doi.org/10.3390/molecules26185655
AMA Style
Jasiecka-Mikołajczyk A, Jaroszewski JJ, Maślanka T.
Oclacitinib, a Janus Kinase Inhibitor, Reduces the Frequency of IL-4- and IL-10-, but Not IFN-γ-, Producing Murine CD4+ and CD8+ T Cells and Counteracts the Induction of Type 1 Regulatory T Cells. Molecules. 2021; 26(18):5655.
https://doi.org/10.3390/molecules26185655
Chicago/Turabian Style
Jasiecka-Mikołajczyk, Agnieszka, Jerzy J. Jaroszewski, and Tomasz Maślanka.
2021. "Oclacitinib, a Janus Kinase Inhibitor, Reduces the Frequency of IL-4- and IL-10-, but Not IFN-γ-, Producing Murine CD4+ and CD8+ T Cells and Counteracts the Induction of Type 1 Regulatory T Cells" Molecules 26, no. 18: 5655.
https://doi.org/10.3390/molecules26185655
APA Style
Jasiecka-Mikołajczyk, A., Jaroszewski, J. J., & Maślanka, T.
(2021). Oclacitinib, a Janus Kinase Inhibitor, Reduces the Frequency of IL-4- and IL-10-, but Not IFN-γ-, Producing Murine CD4+ and CD8+ T Cells and Counteracts the Induction of Type 1 Regulatory T Cells. Molecules, 26(18), 5655.
https://doi.org/10.3390/molecules26185655